Präparat: Lyrica® 20 mg/ml Lösung zum Einnehmen; -25 mg/ -50 mg/ -75 mg/ -100 mg/ -150 mg/ -200 mg/ -225 mg/ -300 mg Hartkapseln
Czerwona Lista / Rote Liste®
Search in Czerwona Lista / Rote Liste®
All databases
Lyrica® 20 mg/ml Lösung zum Einnehmen; -25 mg/ -50 mg/ -75 mg/ -100 mg/ -150 mg/ -200 mg/ -225 mg/ -300 mg Hartkapseln
This content is only available to registered users
If you’re visiting this website the first time and would like to test the database free of charge for ten days, then click here to register once. After you’ve registered, log in with your user name and password.You’re already registered with DrugBase and would like to test the database free of charge for ten days without any further commitment? Then log in here with your access data and select the database you wish to test.
Hauptgruppe
66: Neuropathiepräparate und andere neurotrope Mittel
> 66.B: Chemisch definierte Stoffe
> 66.B.1: Neuropathiepräparate
> 66.B.1.1: Einzelstoffe
>
66.B.1.1.2: Pregabalin
...
...
Hersteller
Zentrale Zulassung
...
Anwendungsgebiete
...
Gegenanzeigen
...
Anwendungsbeschränkungen
...
...
Schwangerschaft
...
Stillzeit
...
Nebenwirkungen
...
...
Wechselwirkungen
...
Intoxikationen
...
Warnhinweise
...
Hinweise
...
Dosierung
...
Copyright
© Rote Liste® Service GmbH, ROTE LISTE® 2020
